NCT06075901

Brief Summary

Blood flow restriction (RFS) is a widely studied technique that combines low-intensity exercise with vascular occlusion, resulting in muscular benefits. However, its application is challenging due to methodological variations and equipment costs. Tissue Flossing (TF) appears as an affordable alternative, but lacks solid scientific evidence.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
136

participants targeted

Target at P50-P75 for not_applicable

Timeline
2mo left

Started Aug 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress92%
Aug 2024Jul 2026

First Submitted

Initial submission to the registry

September 27, 2023

Completed
13 days until next milestone

First Posted

Study publicly available on registry

October 10, 2023

Completed
10 months until next milestone

Study Start

First participant enrolled

August 1, 2024

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2026

Expected
Last Updated

May 31, 2025

Status Verified

May 1, 2025

Enrollment Period

1.3 years

First QC Date

September 27, 2023

Last Update Submit

May 27, 2025

Conditions

Keywords

tissue flossingblood flow restriction

Outcome Measures

Primary Outcomes (15)

  • Occlusion pressures (AOP, 80% and 40% of AOP)

    To determine the AOP, the Doppler equipment transducer will be used, which will be positioned over the posterior tibial artery to capture the auscultatory pulse. A blood pressure cuff will be fixed to the participant's thigh close to the region of the inguinal fold of the dominant limb, and then with the inflatable region of the cuff on the medial portion of the thigh covering the femoral artery, it will be progressively inflated, waiting 15 seconds every 30 mmHg until the point at which the auscultatory pulse of the tibial artery is interrupted.

    First and Secund Stage - [Time Frame: baseline]

  • Assessment of arterial flow and diameter

    A Sonoline Sienna® vascular ultrasound will be used combined with a 40mm B-mode ultrasonic transducer with a 7.5 MHz linear beam, which will be coated with gel for acoustic contact and positioned longitudinally to the posterior tibial artery, enabling variables to be assessed. Doppler flow measurements of MI (peak systolic velocity \[cm/s\], end-diastolic velocity \[cm/s\] and arterial diameter).

    First Stage - [Time Frame: baseline and all subsequent assessments]

  • Perceptual parameter

    The perceptual parameter will be evaluated using a Borg CR10+ scale, representing the perception of discomfort, 0 represents no discomfort and 10 extremely uncomfortable.

    First and Secund Stage - [Time Frame: baseline and all subsequent assessments]

  • Tissue Flossing Assessment

    The application of tissue flossing on the leg will be carried out by always passing the elastic tape with 50% of the tape over the next strip, until the end of the elastic tape.

    First Stage - [Time Frame: The subsequent assessments]

  • Weight

    It will be collected with a weight balance

    First and Secund Stage- [Time Frame: Baseline ]

  • Height

    It will be collected with a stadiometer

    First and Secund Stage- [Time Frame: Baseline ]

  • Body Fat

    It will be collected with a adipometer

    First and Secund Stage- [Time Frame: Baseline ]

  • Arterial pressure

    It will be collected with a sphygmomanometer

    First and Secund Stage- [Time Frame: Baseline ]

  • Perimetry of the dominant lower limb

    It will be defined by the Waterloo Footedness

    First and Secund Stage- [Time Frame: Baseline ]

  • Limb length

    Identified with a measuring tape

    First and Secund Stage- [Time Frame: Baseline ]

  • Perceived exertion scale

    Adapted BORG scale, with 0 being "no effort" and 10 "maximum effort".

    Secund Stage- [Time Frame: at the end of the training sessions]

  • Method preference

    Participants must answer a brief questionnaire about their preference for one of the RFS methods carried out, and justify why they chose it.

    Secund Stage- [Time Frame: final evaluation]

  • 1 Maximum Repetition Test

    The participant must be positioned seated on the extension chair with knees and feet hip-width apart, knees at 90° flexion determined by goniometry, hands holding the handles adjacent to the hips and lumbosacral spine in a firm position in contact with the back of the chair. 1 repetition should be performed to familiarize the movement and 10 repetitions to warm up. At the beginning of the test, they will be instructed to maintain a movement pattern and avoid compensation. The RM is then defined by the highest load at which the participant is capable of performing 1 repetition without compensation.

    Secund Stage- [Time Frame: baseline and final evaluation]

  • Myotonometry

    Myotonometry will be assessed using the MyotonPRO® tool, which consists of a portable, wireless and non-invasive device. The measurement will be carried out once, and in each shot, the following myotonometry parameters will be calculated: the state of tension (tone) and biomechanical properties (rigidity and elasticity).

    Secund Stage- [Time Frame: baseline during follow-up and final evaluation]

  • Ultrasound

    The assessment of the muscular structure will be carried out using ultrasound images of the participant's lower limbs, which will be captured using BodyMetrix BX-2000. Participants will be assessed in the supine position with legs fully extended and muscles relaxed. The ultrasound transducer will be covered with water-soluble transmission gel and positioned perpendicular to the skin over the muscle.

    Secund Stage- [Time Frame: baseline and final evaluation]

Study Arms (2)

Blood Flow Restriction with Cuffing

ACTIVE COMPARATOR

The participant will use the Cuffing for Blood Flow Restriction training

Device: Blood Flow Restriction CuffOther: Training Protocol

Blood Flow Restriction with Tissue Flossing

EXPERIMENTAL

The participant will use Tissue Flossing for Blood Flow Restriction training

Device: Tissue FlossingOther: Training Protocol

Interventions

Tissue Flossing ia a elastic band that when applied exerts an external pressure above or below a muscle or joint of the extremities.

Blood Flow Restriction with Tissue Flossing

Inflatable device that exerts an external pressure above a muscle or joint of the extremities.

Blood Flow Restriction with Cuffing

The lower limb resistance training protocol will follow that recommended in the study by Patterson et al. for resistance training, and will last 4 weeks, with 3 training sessions per week, with a day break between sessions.

Blood Flow Restriction with CuffingBlood Flow Restriction with Tissue Flossing

Eligibility Criteria

Age18 Years - 30 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Individuals who present one or more of the following characteristics will not be included:
  • presence of any health condition that contraindicates or prevents exercise;
  • diabetes and diagnosed high blood pressure;
  • inflammatory, psychiatric, cardiovascular and/or respiratory rheumatological disease; - -4 being dependent on alcohol, consuming drugs and/or being a smoker;
  • history of knee surgery (e.g., meniscal repair and ligament reconstruction) or recent lower limb musculoskeletal injury that may impair performance during tests or interventions (e.g., muscle injury, tendinopathy, patellofemoral pain and/or back pain column in the last six months);
  • use of ergogenic supplements to improve physical performance and/or muscle mass and/or vasoactive medications;
  • having one or more risk factors predisposing to thromboembolism

You may not qualify if:

  • Participants will be excluded from the study if they:
  • have a health problem that does not allow them to continue;
  • wish to leave the study;
  • not sign the consent form

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Franciele Marques Vanderlei

Presidente Prudente, São Paulo, 55, Brazil

Location

MeSH Terms

Conditions

Hypertrophy

Condition Hierarchy (Ancestors)

Pathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

September 27, 2023

First Posted

October 10, 2023

Study Start

August 1, 2024

Primary Completion

December 1, 2025

Study Completion (Estimated)

July 1, 2026

Last Updated

May 31, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations